Xiangxue Pharmaceutical Co.,Ltd. (300147.SZ) SHZ

Currency In CNY

AD

Valuation

Market Cap6B
Enterprise Value7.22B
P/E Ratio-8.04
PEG Ratio-0.24
Price/Sales Ratio2.88
Price/Book Ratio-6.74
Enterprise/Revenue5.61
Enterprise/EBITDA-11.55

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterJune 30, 2026

Profitability

Profit Margin-0.97
Operating Margin-0.46
AD

Management Effectiveness

Return On Assets-0.21
Return On Equity7.43

Income Statement

Revenue1.6B
Revenue/Share2.24
Gross Profit435.94M
EBITDA113.65M
Net Income-1.39B
Diluted EPS-2.11

Balance Sheet

Total Cash177.41M
Total Cash/Share0.27
Total Debt4.2B
Total Debt/Equity-6.69
Current Ratio0.24
Book Value Per Share-0.36

Price History

52-Week Change-42.33
52-Week High11.84
52-Week Low5.9
Moving Average 50 Days7.07
Moving Average 200 Days9

Statistics

Average Volume11.3M
Shares Outstanding658.72M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio-0
Last Split Factor151:125
Last Split DateJune 18, 2015
AD